Oracle launches new version of clinical development analytics

Wednesday, March 28, 2012 11:42 AM

Oracle Health Sciences has introduced the newest version of Oracle Health Sciences Clinical Development Analytics in an effort to help health sciences organizations increase the productivity and effectiveness of their product development programs.

Driven by input from industry partners, the updated application includes new functionality that expands visibility into clinical programs and studies, improves the quality and timeliness of clinical trial data and helps simplify and prioritize the responsibilities of study managers, clinical data managers and site monitors.

The application comes with more than 100 pre-built reports and over 500 pre-built measurements and attributes for custom reporting. It also provides advanced dashboard tailored to clinical trial roles, featuring key performance indicators that identify areas requiring action or attention, such as targeting underperforming sites.

In addition, the solution enables organizations to merge data from multiple clinical trial sources, providing a unified view across operational systems on a single screen. New de-duplication technology supports reports that combine both clinical operations and data management information to monitor enrollment progress, optimize productivity at site visits and help to reduce monitoring-related travel expenses.

The solution is accessible at all times through the Oracle Business Intelligence Mobile application for iPhones and iPads.

Share:          
CWWeekly

June 29

FDA and PatientsLikeMe collaborate to test social media adverse event reporting

Boston-area teaching hospitals launch web portal to attract life science companies

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

July

Integrated research partnerships build momentum
Research function provides infrastructure, leverages large pool of health systems' patients and data

'Right to Try' laws challenge clinical trial process
20 states pass, 20 more pending allowing access to study drugs without FDA and IRB approval

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

June

TransCelerate Biopharma turns three
High-profile consortium has made inroads fixing wasteful practices, but it still has more work ahead

Pharma industry improves its tarnished reputation
Delivering innovation, social responsibility will help rebuild trust

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs